Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Zigeuner

Showing results (101-110 of 166) with videos related to

Pageof 17
Sort By:
European Urology|August 25, 2019
European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019 UpdateMarko Babjuk, Maximilian Burger, Eva M Compérat, et al.
European Urology|June 29, 2020
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2020 UpdateMorgan Rouprêt, Marko Babjuk, Maximilian Burger, et al.
The Journal of Urology|July 21, 2009
Adjuvant chemotherapy for high risk upper tract urothelial carcinoma: results from the Upper Tract Urothelial Carcinoma CollaborationNicholas J Hellenthal, Shahrokh F Shariat, Vitaly Margulis, et al.
European Urology Focus|November 21, 2017
Oncological Outcomes of Laparoscopic Nephroureterectomy Versus Open Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: An European Association of Urology Guidelines Systematic ReviewBenoit Peyronnet, Thomas Seisen, Jose-Luis Dominguez-Escrig, et al.
European Urology|December 19, 2006
Relationship between age at diagnosis and clinicopathologic features of renal cell carcinomaGrégory Verhoest, David Veillard, François Guillé, et al.
BJU International|July 30, 2013
Time to recurrence is a significant predictor of cancer-specific survival after recurrence in patients with recurrent renal cell carcinoma--results from a comprehensive multi-centre database (CORONA/SATURN-Project)Sabine D Brookman-May, Matthias May, Shahrokh F Shariat, et al.
BJU International|November 8, 2008
Stage-specific effect of nodal metastases on survival in patients with non-metastatic renal cell carcinomaUmberto Capitanio, Claudio Jeldres, Jean-Jacques Patard, et al.
BJU International|November 8, 2008
Risk stratification of patients with nodal involvement in upper tract urothelial carcinoma: value of lymph-node densityChristian Bolenz, Shahrokh F Shariat, Mario I Fernández, et al.
BJU International|November 17, 2009
Advanced patient age is associated with inferior cancer-specific survival after radical nephroureterectomyShahrokh F Shariat, Guilherme Godoy, Yair Lotan, et al.
The Journal of Urology|February 26, 2013
Impact of clinical and histopathological parameters on disease specific survival in patients with collecting duct renal cell carcinoma: development of a disease specific risk modelMatthias May, Vincenzo Ficarra, Shahrokh F Shariat, et al.
Pageof 17

Showing results (101-110 of 166) with videos related to

Sort By:
Pageof 17
European Urology|August 25, 2019
European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019 UpdateMarko Babjuk, Maximilian Burger, Eva M Compérat, et al.
European Urology|June 29, 2020
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2020 UpdateMorgan Rouprêt, Marko Babjuk, Maximilian Burger, et al.
The Journal of Urology|July 21, 2009
Adjuvant chemotherapy for high risk upper tract urothelial carcinoma: results from the Upper Tract Urothelial Carcinoma CollaborationNicholas J Hellenthal, Shahrokh F Shariat, Vitaly Margulis, et al.
European Urology Focus|November 21, 2017
Oncological Outcomes of Laparoscopic Nephroureterectomy Versus Open Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: An European Association of Urology Guidelines Systematic ReviewBenoit Peyronnet, Thomas Seisen, Jose-Luis Dominguez-Escrig, et al.
European Urology|December 19, 2006
Relationship between age at diagnosis and clinicopathologic features of renal cell carcinomaGrégory Verhoest, David Veillard, François Guillé, et al.
BJU International|July 30, 2013
Time to recurrence is a significant predictor of cancer-specific survival after recurrence in patients with recurrent renal cell carcinoma--results from a comprehensive multi-centre database (CORONA/SATURN-Project)Sabine D Brookman-May, Matthias May, Shahrokh F Shariat, et al.
BJU International|November 8, 2008
Stage-specific effect of nodal metastases on survival in patients with non-metastatic renal cell carcinomaUmberto Capitanio, Claudio Jeldres, Jean-Jacques Patard, et al.
BJU International|November 8, 2008
Risk stratification of patients with nodal involvement in upper tract urothelial carcinoma: value of lymph-node densityChristian Bolenz, Shahrokh F Shariat, Mario I Fernández, et al.
BJU International|November 17, 2009
Advanced patient age is associated with inferior cancer-specific survival after radical nephroureterectomyShahrokh F Shariat, Guilherme Godoy, Yair Lotan, et al.
The Journal of Urology|February 26, 2013
Impact of clinical and histopathological parameters on disease specific survival in patients with collecting duct renal cell carcinoma: development of a disease specific risk modelMatthias May, Vincenzo Ficarra, Shahrokh F Shariat, et al.
Pageof 17